%PDF-1.4
%
1 0 obj
<>
endobj
214 0 obj
<>stream
Creo Normalizer JTP
2024-03-19T02:03:34-07:00
2006-07-11T13:11:39-04:00
2024-03-19T02:03:34-07:00
uuid:f08a9089-935c-4b69-80fb-00352bbce623
uuid:a6acec33-1dd1-11b2-0a00-8800d853bbff
application/pdf
endstream
endobj
2 0 obj
<>
endobj
6 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/TrimBox[0.0 0.0 585.0 783.0]/Type/Page>>
endobj
68 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/TrimBox[0.0 0.0 585.0 783.0]/Type/Page>>
endobj
123 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/TrimBox[0.0 0.0 585.0 783.0]/Type/Page>>
endobj
167 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/TrimBox[0.0 0.0 585.0 783.0]/Type/Page>>
endobj
232 0 obj
[237 0 R]
endobj
209 0 obj
<>
endobj
233 0 obj
<>stream
BT
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
10 0 1.554 10 35.1648 729.8835 Tm
(\002)Tj
/T1_1 1 Tf
10 0 0 10 41.2744 729.8835 Tm
(4)Tj
/T1_0 1 Tf
10 0 1.554 10 46.8341 729.8835 Tm
(\001)Tj
/T1_1 1 Tf
10 0 0 10 52.9437 729.8835 Tm
[(2)-332.9 (Nicotinic)-332.9 (Receptors)-332.9 (with)-332.9 (High)-332.9 (and)-332.9 (Low)-332.9 (Acetylcholine)-332.9 (Sensitivity:)-332.9 (Pharmacology,)-332.9 (Stoichiometry,)]TJ
0.2221 -1.2 Td
[(and)-332.9 (Sensitivity)-332.9 (to)-332.9 (Long-Term)-332.9 (Exposure)-332.9 (to)-332.9 (Nicotine)]TJ
/T1_2 1 Tf
0 -1.2 TD
[(Mirko)-332.9 (Moroni,)-332.9 (Ruud)-332.9 (Zwart,)-332.9 (Emanuele)-332.9 (Sher,)-332.9 (Bruce)-332.9 (K.)-332.9 (Cassels,)-332.9 (and)-332.9 (Isabel)-332.9 (Bermudez)]TJ
/T1_1 1 Tf
47.9329 0 Td
(755)Tj
-49.9329 -2.2 Td
[(Capacitative)-332.9 (and)-332.9 (1-Oleyl-2-acetyl-)]TJ
/T1_2 1 Tf
15.889 0 Td
(sn)Tj
/T1_1 1 Tf
[0.1 (-glycerol-Activated)-332.9 (Ca)]TJ
7.5 0 0 6.5 307.5474 688.1335 Tm
(2)Tj
/T1_3 1 Tf
(\002)Tj
/T1_1 1 Tf
10 0 0 10 321.2944 683.8835 Tm
[(Entry)-332.9 (Distinguished)-332.9 (Using)-332.9 (Adenylyl)]TJ
-26.613 -1.2 Td
[(Cyclase)-332.9 (Type)-332.9 (8)]TJ
/T1_2 1 Tf
T*
[(Agnes)-332.9 (C.)-332.9 (L.)-332.9 (Martin)-332.9 (and)-332.9 (Dermot)-332.9 (M.)-332.9 (F.)-332.9 (Cooper)]TJ
/T1_1 1 Tf
47.9329 0 Td
(769)Tj
/T1_4 1 Tf
9 0 0 9 35.1648 85.3835 Tm
(\001)Tj
/T1_1 1 Tf
7 0 0 7 37.5962 85.3835 Tm
(S)Tj
10 0 0 10 47.0063 85.3835 Tm
[(Supplemental)-332.9 (material)-332.9 (is)-332.9 (available)-332.9 (online)-332.9 (at)-332.9 (http://molpharm.aspetjournals.org.)]TJ
/T1_2 1 Tf
8 0 0 8 50.1648 50.3835 Tm
[(About)-286.6 (the)-286.6 (cover:)]TJ
/T1_1 1 Tf
7.6186 0 Td
[(Molecular)-286.6 (model)-286.6 (of)-286.6 (NSC-87877)-286.6 (binding)-286.6 (to)-286.6 (the)-286.6 (Shp2)-286.6 (PTP)-286.6 (domain.)-286.6 (See)-286.6 (the)-286.6 (article)-286.6 (by)-286.6 (Chen)-286.6 (et)-286.6 (al.)-286.6 (on)-286.6 (page)-286.6 (562)-286.6 (of)-286.6 (this)]TJ
-7.6186 -1.25 Td
(issue.)Tj
ET
1 0 0 1 -9 -9 cm
/CS0 CS 1 SCN
48.5 w
/GS1 gs
44.165 58.134 m
47.165 58.134 l
S
3 w
47.165 80.884 m
558.165 80.884 l
S
48.5 w
555.165 58.134 m
558.165 58.134 l
S
3 w
44.165 35.383 m
555.165 35.383 l
S
1 0 0 1 9 9 cm
BT
0 g
/GS2 gs
/T1_5 1 Tf
0 -9 9 0 568 377.75706 Tm
( at ASPET Journals on March 19, 2024)Tj
/GS2 gs
-11.22099 0 Td
(molpharm.aspetjournals.org)Tj
/GS2 gs
-7.55399 0 Td
(Downloaded from )Tj
ET
endstream
endobj
194 0 obj
<>
endobj
170 0 obj
<>
endobj
174 0 obj
<>
endobj
177 0 obj
<>
endobj
181 0 obj
<>
endobj
185 0 obj
<>
endobj
222 0 obj
<>
endobj
186 0 obj
<>
endobj
188 0 obj
<>
endobj
187 0 obj
<>stream
HTPMk0Wر@n!PZ
9샥ݵFqӴc=ГI[r'{aޑeኃ#P%Xg֭hF@&qLǖzu-WN؝[dGnG4
X